Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Intel Strategy for Achieving Wealth and Off Topic -- Ignore unavailable to you. Want to Upgrade?

To: Sonki who wrote (22242)	1/5/1999 12:17:00 PM
From: Sonny McWilliams	Respond to of 27012

Sonki. PFE. It is comarketing the Drug from MTC. But MTC's statement was a bit misleading. FDA did not allow them to claim that it is better for the stomach. I sold MTC the next business day which was yesterday. I hate to be misled or at least that orig. article did not mention anything about what the FDA told MTC in regard of not being able to claim that this medication is better for the stomach than the rest of arthritis medication. And I understand that Merck could be a better drug and it is supposed to come out around June compared to MTC in Feb. So I guess all this put a damper on MTC and PFE. MTC is still working on getting approval to claim better stomach tolerance with more clinical trials. PFE has their own pipeline and PFE WAS recommended for the new year by sev. analyst's. Nice going with Amzn. Did not look that bright orig. when earnings were discussed. I am happy with my new Nokia purchase around 120 from last week. Too bad I did not get TEF again. Telecommunication is still in. BTW, Abbey is now saying that this year is a stock pickers market. Yes, I heard about SUNW. Just don't feel like picking it up at this price. I was waiting for it to come down but.... 50 was the time to get in again. gg. Sonny